Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06559267 · ClinicalTrials.gov registry record · NA
School-based Paraeducator Education for Engagement at Recess
A NA study of Autism Spectrum Disorder and Neurodevelopmental Disorders, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 3
- Study locations
NCT06559267: Recruiting NA study of Autism Spectrum Disorder and Neurodevelopmental Disorders, sponsored by University of Washington.
NCT06559267 is a NA study of Autism Spectrum Disorder and Neurodevelopmental Disorders that is actively recruiting participants, run by University of Washington. The registered enrollment target is 350 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (161% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06559267, a NA study of Autism Spectrum Disorder and Neurodevelopmental Disorders, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of the proposed three-site study is to test whether an educator-level implementation strategy, coaching, with or without a school-level implementation strategy, school-based teams, will maximize paraeducators' use (fidelity and sustainment) of an evidence-based social engagement intervention, Remaking Recess (RR). RR aims to improve peer related social skills for autistic students and their non-autistic peers who are socially isolated or peripheral and need support during recess.
Primary Outcome
This 20-item observation measure rates how well educators are observed to be using core Remaking Recess strategies with students on the playground. Minimum score 1, maximum score 5. Higher scores indicate better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Remaking Recess
- OTHER TEAM
Study Locations (3)
California
- University of California Los Angeles - Los Angeles
Oregon
- University of Oregon - Eugene
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2029-08 |
| Phase | NA |
What NCT06559267 shows while recruiting
NCT06559267 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (161% higher).
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Remaking Recess is the first listed.
NCT06559267 reports a single indexed study location in California, Oregon, Washington.
Frequently Asked Questions
What is clinical trial NCT06559267 about?
NCT06559267 is a clinical study titled "School-based Paraeducator Education for Engagement at Recess". The purpose of the proposed three-site study is to test whether an educator-level implementation strategy, coaching, with or without a school-level implementation strategy, school-based teams, will maximize paraeducators' use (fidelity and sustainment) of an evidence-based social engagement interven...
What is the current status of trial NCT06559267?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-07-01. Estimated completion is 2029-08.
What conditions does trial NCT06559267 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Neurodevelopmental Disorders.
What interventions are being tested in trial NCT06559267?
The interventions under investigation include: Remaking Recess (BEHAVIORAL), TEAM (OTHER).
Who is sponsoring clinical trial NCT06559267?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06559267 being conducted?
This trial has 3 study locations across California, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06559267's enrollment target sits among peer trials
350 21st of 224 higher than 203 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI